NCT04014946View on ClinicalTrials.gov

Assessment of Risk Factors for Appropriate ICD (Implantable Cardioverter-defibrillator) Intervention in Patients With Ischemic Cardiomyopathy

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 24, 2012

Primary Completion Date

May 28, 2020

Study Completion Date

July 22, 2020

Conditions
ICDCardiomyopathy IschemicPrimary Prevention
Interventions
DEVICE

ICD implantation

implantation of the Lumax 540 single/dual chamber ICD or successor

All Listed Sponsors
lead

Biotronik SE & Co. KG

INDUSTRY

NCT04014946 - Assessment of Risk Factors for Appropriate ICD (Implantable Cardioverter-defibrillator) Intervention in Patients With Ischemic Cardiomyopathy | Biotech Hunter | Biotech Hunter